CAPTRUST Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.93M Sell
13,312
-218
-2% -$97.1K 0.01% 580
2025
Q1
$6.56M Buy
13,530
+1,482
+12% +$719K 0.02% 520
2024
Q4
$4.85M Sell
12,048
-2,361
-16% -$951K 0.01% 555
2024
Q3
$6.7M Buy
14,409
+307
+2% +$143K 0.02% 460
2024
Q2
$6.61M Sell
14,102
-2,546
-15% -$1.19M 0.02% 442
2024
Q1
$6.96M Sell
16,648
-5,461
-25% -$2.28M 0.03% 421
2023
Q4
$9M Buy
22,109
+3,245
+17% +$1.32M 0.03% 391
2023
Q3
$6.56M Sell
18,864
-2,210
-10% -$769K 0.03% 431
2023
Q2
$7.42M Buy
21,074
+528
+3% +$186K 0.03% 383
2023
Q1
$6.47M Buy
20,546
+1,052
+5% +$331K 0.03% 395
2022
Q4
$5.63M Sell
19,494
-26
-0.1% -$7.51K 0.03% 409
2022
Q3
$5.65M Sell
19,520
-930
-5% -$269K 0.03% 372
2022
Q2
$5.76M Buy
20,450
+1,012
+5% +$285K 0.04% 340
2022
Q1
$5.07M Buy
19,438
+2,752
+16% +$718K 0.03% 365
2021
Q4
$3.66M Sell
16,686
-2,612
-14% -$574K 0.03% 430
2021
Q3
$3.5M Buy
19,298
+3,685
+24% +$668K 0.03% 394
2021
Q2
$3.15M Buy
15,613
+10,833
+227% +$2.18M 0.03% 382
2021
Q1
$1.03M Buy
4,780
+3,107
+186% +$668K 0.01% 690
2020
Q4
$395K Sell
1,673
-2,938
-64% -$694K 0.01% 922
2020
Q3
$1.26M Buy
4,611
+647
+16% +$177K 0.02% 439
2020
Q2
$1.14M Buy
3,964
+2,248
+131% +$644K 0.02% 464
2020
Q1
$387K Buy
1,716
+752
+78% +$170K 0.01% 648
2019
Q4
$212K Buy
964
+736
+323% +$162K ﹤0.01% 961
2019
Q3
$39K Buy
228
+6
+3% +$1.03K ﹤0.01% 1077
2019
Q2
$41K Buy
222
+149
+204% +$27.5K ﹤0.01% 1052
2019
Q1
$13K Sell
73
-21
-22% -$3.74K ﹤0.01% 1323
2018
Q4
$16K Sell
94
-19
-17% -$3.23K ﹤0.01% 1090
2018
Q3
$22K Buy
113
+8
+8% +$1.56K ﹤0.01% 975
2018
Q2
$18K Buy
105
+52
+98% +$8.91K ﹤0.01% 990
2018
Q1
$8K Sell
53
-2
-4% -$302 ﹤0.01% 1091
2017
Q4
$8K Buy
55
+18
+49% +$2.62K ﹤0.01% 1053
2017
Q3
$6K Buy
+37
New +$6K ﹤0.01% 477